These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29210664)

  • 1. Advances in the Discovery of Anthraquinone-Based Anticancer Agents.
    Tikhomirov AS; Shtil AA; Shchekotikhin AE
    Recent Pat Anticancer Drug Discov; 2018; 13(2):159-183. PubMed ID: 29210664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel anthraquinone compounds as anticancer agents and their potential mechanism.
    Tian W; Wang C; Li D; Hou H
    Future Med Chem; 2020 Apr; 12(7):627-644. PubMed ID: 32175770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer drug discovery in the future: an evolutionary perspective.
    Ma X; Wang Z
    Drug Discov Today; 2009 Dec; 14(23-24):1136-42. PubMed ID: 19800414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the computer-aided drug design and discovery based on anthraquinone scaffold for cancer treatment: A systematic review.
    Chua HM; Moshawih S; Kifli N; Goh HP; Ming LC
    PLoS One; 2024; 19(5):e0301396. PubMed ID: 38776291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthracycline and anthraquinone anticancer agents: current status and recent developments.
    Lown JW
    Pharmacol Ther; 1993 Nov; 60(2):185-214. PubMed ID: 8022857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor potential of aza-bioisosterism in anthracenedione-based drugs.
    Sissi C; Palumbo M
    Curr Top Med Chem; 2004; 4(2):219-30. PubMed ID: 14754455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthraquinone: a promising scaffold for the discovery and development of therapeutic agents in cancer therapy.
    Siddamurthi S; Gutti G; Jana S; Kumar A; Singh SK
    Future Med Chem; 2020 Jun; 12(11):1037-1069. PubMed ID: 32349522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and development of natural product oridonin-inspired anticancer agents.
    Ding Y; Ding C; Ye N; Liu Z; Wold EA; Chen H; Wild C; Shen Q; Zhou J
    Eur J Med Chem; 2016 Oct; 122():102-117. PubMed ID: 27344488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New 1,4-anthracene-9,10-dione derivatives as potential anticancer agents.
    Zagotto G; Supino R; Favini E; Moro S; Palumbo M
    Farmaco; 2000 Jan; 55(1):1-5. PubMed ID: 10755224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fruitful decade from 2005 to 2014 for anthraquinone patents.
    Hussain H; Al-Harrasi A; Al-Rawahi A; Green IR; Csuk R; Ahmed I; Shah A; Abbas G; Rehman NU; Ullah R
    Expert Opin Ther Pat; 2015; 25(9):1053-64. PubMed ID: 26036306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antitumor activity of cyclopentane-fused anthraquinone derivatives.
    Tikhomirov AS; Sinkevich YB; Dezhenkova LG; Kaluzhny DN; Ilyinsky NS; Borshchevskiy VI; Schols D; Shchekotikhin AE
    Eur J Med Chem; 2024 Feb; 265():116103. PubMed ID: 38176358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on Redox Properties and Cytotoxicity of Anthraquinone Derivatives to Understand Antitumor Active Anthracycline Substances.
    Okumura N; Mizutani H; Ishihama T; Ito M; Hashibe A; Nakayama T; Uno B
    Chem Pharm Bull (Tokyo); 2019; 67(7):717-720. PubMed ID: 31257327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advancement in discovery and development of natural product combretastatin-inspired anticancer agents.
    Patil PO; Patil AG; Rane RA; Patil PC; Deshmukh PK; Bari SB; Patil DA; Naphade SS
    Anticancer Agents Med Chem; 2015; 15(8):955-69. PubMed ID: 26007283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural products and their analogues as efficient anticancer drugs.
    Coseri S
    Mini Rev Med Chem; 2009 May; 9(5):560-71. PubMed ID: 19456286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthraquinones As Pharmacological Tools and Drugs.
    Malik EM; Müller CE
    Med Res Rev; 2016 Jul; 36(4):705-48. PubMed ID: 27111664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esters of 2-(1-hydroxyalkyl)-1,4-dihydroxy-9,10-anthraquinones with melphalan as multifunctional anticancer agents.
    Jin G; You Y; Ahn B
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1473-6. PubMed ID: 11378380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungal Anticancer Metabolites: Synthesis Towards Drug Discovery.
    Barbero M; Artuso E; Prandi C
    Curr Med Chem; 2018; 25(2):141-185. PubMed ID: 28494746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Survey of Marine Natural Compounds and Their Derivatives with Anti-cancer Activity Reported in 2012.
    Sawadogo WR; Boly R; Cerella C; Teiten MH; Dicato M; Diederich M
    Molecules; 2015 Apr; 20(4):7097-142. PubMed ID: 25903364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marine-derived drugs: Recent advances in cancer therapy and immune signaling.
    Saeed AFUH; Su J; Ouyang S
    Biomed Pharmacother; 2021 Feb; 134():111091. PubMed ID: 33341044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microtubule-targeting anticancer agents from marine natural substance.
    Liu Z; Xu P; Wu T; Zeng W
    Anticancer Agents Med Chem; 2014 Mar; 14(3):409-17. PubMed ID: 24533652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.